SIRT1 activation through NAD+ availability triggers multiple metabolic improvements: enhanced insulin sensitivity, increased mitochondrial biogenesis, improved fat oxidation, reduced inflammation, and enhanced stress resistance
By age 60, levels drop to around 80 ng/mL, a 60% reduction
The most common side effects are mild and may include pain or redness at the injection site, mild diarrhea, nausea, or a feeling of swelling all over the body
Enrolment & Further Information: To enrol please use our contact form
Structurally a close cousin of GHK-Cu, AHK-Cu has become a focused subject of preclinical investigation, particularly in studies relating to hair follicle biology, dermal cell research, and copper-mediated signalling pathways